On October 27, the Huizhou Municipal Bureau of Ecology and Environment released the acceptance information announcement for the New Energy Solid-State Battery Materials Project of Jinlongyu New Energy (Huidong) Co., Ltd.
According to the…
Blog
-
This new AI browser lets you set up ‘Skills’ to take on your everyday tasks – how it works
MirageC/Moment via Getty Images Follow ZDNET: Add us as a preferred source on Google.
ZDNET’s key takeaways
- Strawberry Browser is a new agentic browser.
- With Skills, you can make repetitive tasks even simpler.
- These skills can be used for all…
Continue Reading
-
Melissa Gorga on Wife Swap, RHONJ Season 15, Teresa Reconciliation
Melissa Gorga is happy to be back on reality television with Wife Swap: The Real Housewives Edition, but she’s also more than ready for The Real Housewives of New Jersey to make its grand return.
“I’m excited to have a little catch…
Continue Reading
-
New lizard species discovered with sharp, knife-like spines
Scientists have described a new lizard species from Vietnam, naming it Acanthosaura grismeri. The discovery adds a spiny backed member to a genus already rich in Southeast Asia and highlights how much biodiversity remains hidden in the…
Continue Reading
-
Takehiro Hira Honored With The Hollywood Reporter’s Trailblazer Award
Takehiro Hira‘s late career success streak continued on Tuesday night in Tokyo, as the in-demand Japanese actor was awarded The Hollywood Reporter‘s Trailblazer Award at a swanky gala event held at the sky-high Roppongi Hills Club.
Continue Reading
Tata Motors confirms it fixed security flaws, which exposed company and customer data
Indian automotive giant Tata Motors has fixed a series of security flaws that exposed sensitive internal data, including personal information of customers, company reports, and data related to its dealers.
Security researcher Eaton Zveare told…
Continue Reading
Neural Dispatch: Agentic AI’s lack of intelligence, a DeepSeek moment, and Nvidia’s AI supercomputer (HT Tech)
Cognitive warmup. Is this another DeepSeek moment for AI to contend with? Chinese tech giants Alibaba says their Alibaba Cloud platform has successfully tested a new compute pooling system called Aegaeon, which has reduced the number of Nvidia…
Continue Reading
Jofra Archer returns for England as New Zealand wins the toss and bowls in the 2nd cricket ODI
HAMILTON, New Zealand (AP) — New Zealand won a delayed toss and chose to bowl Wednesday in the second one-day…
…
Continue Reading
Thermo Fisher nears $10bn takeover of drug trial software maker Clario
Stay informed with free updates
Simply sign up to the Health sector myFT Digest — delivered directly to your inbox.
Life sciences group Thermo Fisher is nearing a takeover of drug trial software maker Clario in a deal that could value the healthcare technology group at approximately $10bn.
The all-cash deal could be announced as early as Wednesday provided it does not hit any last-minute snags, according to two people familiar with the matter.
The acquisition would give Thermo Fisher access to a platform that is playing an increasingly critical role in managing the clinical data essential to drug trials. Clario’s technology has been used across 26,000 trials in more than 100 countries, generating as much as $400mn a year in adjusted earnings.
If a sale materialises, it would mark one of the biggest full private equity exits of the year.
Founded in 2021 by a merger of health tech groups ERT and Bioclinica, Clario is majority owned by Stockholm-based private equity group Nordic Capital. It also counts Astorg Partners, Novo Holdings and Cinven as minority investors. Clario’s private equity backers had until recently been considering a public listing for the group.
Thermo Fisher, Clario, Nordic, Astorg, Novo Holdings and Cinven did not immediately respond to requests for comment.
The deal would mark Thermo Fisher’s biggest acquisition since 2021 when the Massachusetts-based group bought contract research organisation PPD in a deal worth $17.4bn. Earlier this year, Thermo Fisher struck a $4.1bn deal to buy Solventum’s filtration unit.
It comes amid a volatile period for Thermo Fisher and the wider healthcare sector. Shares in Thermo Fisher dropped earlier this year as investors fretted over the impact of President Donald Trump’s cuts to the National Institutes of Health on its sales, but they have since rallied.
Thermo Fisher shares are up 6 per cent this year, giving it a market capitalisation of $210bn.
Continue Reading
